SARAH CHALK: Open Payments
NPI 1104590801 · UNION, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 34 payments from 20 companies in 2025. Trend: 2023 $520 · 2024 $738 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $114 |
| Exact Sciences Corporation | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Tris Pharma Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
Products named: Wegovy, Jornay PM, REXULTI, The Cologuard Plus Collection Kit, MOUNJARO, Ozempic, Dyanavel XR, CAPLYTA.
Industry payments across MO — which companies pay providers there.
